Clinical Trials Browser

INDUSTRY × PSR Ovarian Cancer With a BRCA Mutation × olaparib × Clear all

NCT03063710 2018-05-17

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

No longer available

PSR Ovarian Cancer With a BRCA Mutation